Literature DB >> 26121305

Contemporary Nationwide Patterns of Active Surveillance Use for Prostate Cancer.

Matthew J Maurice1, Robert Abouassaly2, Simon P Kim2, Hui Zhu3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26121305     DOI： 10.1001/jamainternmed.2015.2835

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  11 in total

1.  Selecting Active Surveillance: Decision Making Factors for Men with a Low-Risk Prostate Cancer.

Authors:  Richard M Hoffman; Tania Lobo; Stephen K Van Den Eeden; Kimberly M Davis; George Luta; Amethyst D Leimpeter; David Aaronson; David F Penson; Kathryn Taylor
Journal:  Med Decis Making       Date:  2019-10-21       Impact factor: 2.583

2.  Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic Review.

Authors:  Netty Kinsella; Pär Stattin; Declan Cahill; Christian Brown; Anna Bill-Axelson; Ola Bratt; Sigrid Carlsson; Mieke Van Hemelrijck
Journal:  Eur Urol       Date:  2018-03-26       Impact factor: 20.096

3.  Analysis of active surveillance uptake for low-risk localized prostate cancer in Canada: a Canadian multi-institutional study.

Authors:  Narhari Timilshina; Veronique Ouellet; Shabbir M H Alibhai; Anne-Marie Mes-Masson; Nathalie Delvoye; Darrel Drachenberg; Antonio Finelli; Marie-Paule Jammal; Pierre Karakiewicz; Hélène Lapointe; Jean-Baptiste Lattouf; Kenny Lynch; Jean-Benoît Paradis; Paula Sitarik; Alan So; Fred Saad
Journal:  World J Urol       Date:  2016-07-22       Impact factor: 4.226

Review 4.  Prolaris Cell Cycle Progression Test for Localized Prostate Cancer: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2017-05-01

5.  Robotic prostatectomy is associated with increased patient travel and treatment delay.

Authors:  Matthew J Maurice; Hui Zhu; Simon P Kim; Robert Abouassaly
Journal:  Can Urol Assoc J       Date:  2016 May-Jun       Impact factor: 1.862

6.  Determinants for choosing and adhering to active surveillance for localised prostate cancer: a nationwide population-based study.

Authors:  Oskar Bergengren; Hans Garmo; Ola Bratt; Lars Holmberg; Eva Johansson; Anna Bill-Axelson
Journal:  BMJ Open       Date:  2019-12-23       Impact factor: 2.692

7.  Trends and practices for managing low-risk prostate cancer: a SEER-Medicare study.

Authors:  Richard M Hoffman; Sarah L Mott; Bradley D McDowell; Sonia T Anand; Kenneth G Nepple
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-06-09       Impact factor: 5.455

8.  MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.

Authors:  Veeru Kasivisvanathan; Antti S Rannikko; Marcelo Borghi; Valeria Panebianco; Lance A Mynderse; Markku H Vaarala; Alberto Briganti; Lars Budäus; Giles Hellawell; Richard G Hindley; Monique J Roobol; Scott Eggener; Maneesh Ghei; Arnauld Villers; Franck Bladou; Geert M Villeirs; Jaspal Virdi; Silvan Boxler; Grégoire Robert; Paras B Singh; Wulphert Venderink; Boris A Hadaschik; Alain Ruffion; Jim C Hu; Daniel Margolis; Sébastien Crouzet; Laurence Klotz; Samir S Taneja; Peter Pinto; Inderbir Gill; Clare Allen; Francesco Giganti; Alex Freeman; Stephen Morris; Shonit Punwani; Norman R Williams; Chris Brew-Graves; Jonathan Deeks; Yemisi Takwoingi; Mark Emberton; Caroline M Moore
Journal:  N Engl J Med       Date:  2018-03-18       Impact factor: 176.079

9.  Who and when should we screen for prostate cancer? Interviews with key opinion leaders.

Authors:  Sigrid Carlsson; Michael Leapman; Peter Carroll; Fritz Schröder; Peter C Albertsen; Dragan Ilic; Michael Barry; Dominick L Frosch; Andrew Vickers
Journal:  BMC Med       Date:  2015-11-27       Impact factor: 8.775

Review 10.  Green tea extract for prevention of prostate cancer progression in patients on active surveillance.

Authors:  Nagi B Kumar; Shohreh I Dickinson; Michael J Schell; Brandon J Manley; Michael A Poch; Julio Pow-Sang
Journal:  Oncotarget       Date:  2018-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.